Hearing Loss Linked with Increased Risk of Dementia
HCPLive
JANUARY 4, 2024
In a new study, hearing loss was significantly associated with a 7% higher risk of dementia, while hearing aids were shown to reduce such risks.
Thu.Jan 04, 2024
122 
Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure
DAIC
JANUARY 4, 2024
Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health. Image courtesy of Hentry Ford Health milla1cf Thu, 01/04/2024 - 10:55 January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart Disease team show that severe mitral stenosis, due to a build-up of calcium deposits in the mitral valve common in elderly patients, can be safely and successfully treated using Intravascular lithotripsy (IVL)-enabled percuta
The Cumulative Burden of LDL-C
HCPLive
JANUARY 4, 2024
Expert cardiologists discuss the cumulative burden of an elevated cholesterol over time.
Florida cardiologists extract heart tumor with catheter
Becker's Hospital Review - Cardiology
JANUARY 4, 2024
HCA Florida Largo Hospital cardiologists were the first in the state to successfully remove a tumor from inside a patient's heart without open heart surgery.
Mechanism of Action of Nonstatin Therapies
HCPLive
JANUARY 4, 2024
Dr Kohli gives an overview of the mechanisms of action of non-statin agents for the management of hyperlipidemia.
Fasting Before Cardiac Catheterization May Be Unnecessary
DAIC
JANUARY 4, 2024
Credit: American Association of Critical-Care Nurses milla1cf Thu, 01/04/2024 - 11:00 January 4, 2024 — The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of evidence grows to allow patients to eat before the procedure. Patients undergoing coronary artery catheterization are typically required to take nothing by mouth after midnight prior to their procedure, but there is no evidence to support this long-standing practice.
FDA Accepts Biologics License Application for Ustekinumab Biosimilar DMB-3115
HCPLive
JANUARY 4, 2024
BLA submission was based on data from phase 3 clinical trials in which DMB-3115 showed no clinically meaningful differences compared with the reference product for the treatment of plaque psoriasis.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Emerging Agents in The Treatment of Gout
HCPLive
JANUARY 4, 2024
In this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.
AI-driven study redefines right heart health assessment with novel predictive model
Medical Xpress - Cardiology
JANUARY 4, 2024
In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart's right ventricle, which sends blood to the lungs.
Acetylcholinesterase Inhibitors for Alzheimer Disease May Reduce AMD Risk
HCPLive
JANUARY 4, 2024
A retrospective cohort study showed patients with Alzheimer disease treated with AChEIs had a slightly lower risk of incident AMD compared with untreated patients.
In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective
Med Page Today
JANUARY 4, 2024
(MedPage Today) -- SGLT2 inhibitors significantly lowered the risk of death, major adverse kidney events (MAKE), and major adverse cardiovascular events (MACE) in people with type 2 diabetes and acute kidney disease, according to a cohort study.
SGLT-2is Mitigate Risk of Cardiovascular, Kidney Diseases in Patients with Type 2 Diabetes and AKD
HCPLive
JANUARY 4, 2024
Compared to nonusers, patients with type 2 diabetes and acute kidney disease administered SGLT-2is had a significantly lower risk of mortality, major adverse kidney events, and major adverse cardiovascular events.
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists
Med Page Today
JANUARY 4, 2024
(MedPage Today) -- Several years after initiating treatment, GLP-1 receptor agonist users didn't have a pancreatic cancer safety signal, a historical cohort study reported. Compared with basal insulin users, those on a GLP-1 receptor agonist didn.
Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2
American College of Cardiology
JANUARY 4, 2024
The goal of the STOPDAPT-2 trial was to evaluate 1-month dual antiplatelet therapy (DAPT) compared with 12-month DAPT among patients undergoing percutaneous coronary intervention (PCI).
Dermatology Month in Review: December 2023
HCPLive
JANUARY 4, 2024
The December 2023 month in review for dermatology covers major stories regarding a new FDA approval, several new treatment findings, and news on attitudes toward those with acne.
TMS for Psych Disorders Poses Little Threat to Implanted Cardiac Devices
Med Page Today
JANUARY 4, 2024
(MedPage Today) -- An electromagnetic therapy for depression shouldn't damage a person's pre-existing implantable cardioverter-defibrillator (ICD), multiple experiments indicated. There was a low risk of ICD damage or overheating during transcranial.
Plasma levels of autophagy regulator Rubicon are inversely associated with acute coronary syndrome
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Background The discovery of novel biomarkers that improve current cardiovascular risk prediction models of acute coronary syndrome (ACS) is needed for the identification of very high-risk patients and therapeutic decision-making. Autophagy is a highly conserved catabolic mechanism for intracellular degradation of cellular components through lysosomes.
Rheumatology Month in Review: December 2023
HCPLive
JANUARY 4, 2024
The rheumatology month in review highlights fibromyalgia complexities, lupus advancements, and dietary links to gout for improved management.
A Bayesian network-based approach for identifying risk factors and predicting ischemic stroke in infective endocarditis patients
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Objective This study aimed to seek the risk factors and develop a predictive model for ischemic stroke (IS) in patients with infective endocarditis (IE) utilizing a Bayesian network (BN) approach. Methods Data were obtained from the electronic medical records of all adult patients at three hospitals between 1 January 2018, and 31 December 2022. Two predictive models, logistic regression and BN, were used.
Arrhythmic Mitral Valve Prolapse in Unexplained Cardiac Arrest
American College of Cardiology
JANUARY 4, 2024
What is the prevalence and what are the characteristics of mitral valve prolapse (MVP) in a large cohort of patients with unexplained cardiac arrest (UCA)?
Editorial: Response to cardiac resynchronization therapy
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Since the implantation of the first pacemakers in the 1960s, rapid advancements in biomedical technologies have led to the development of Cardiac Resynchronization Therapy (CRT) in the 1990s. Landmark randomized controlled trials conducted in the early 2000s demonstrated the reduction of mortality and morbidity by the use of de novo CRT in heart failure (HF) patients with a reduced ejection fraction (HFrEF) and intrinsic, wide QRS complex. (1,2) Moreover, now evidence on CRT upgrade with hard ou
ACC Announces 2024 Slate of Distinguished Award Winners
American College of Cardiology
JANUARY 4, 2024
The ACC is proud to announce the slate of 2024 Distinguished Award winners – an inspiring group of women and men who have, and continue to, make significant contributions in transforming cardiovascular care and improving heart health around the world.
Unveiling a Year of Medical Excellence: Celebrating 2023's Milestones and Beyond
ADN Center of Excellence
JANUARY 4, 2024
As we bid farewell to an extraordinary year, we stand in awe of the incredible journey we've embarked upon in 2023. It's with immense pride and joy that we reflect on the milestones and accomplishments achieved by our collective dedication to advancing medical education and innovation. The canvas of 2023 was painted with vibrant hues of knowledge and expertise, marked by a plethora of events and trainings that illuminated the path toward medical excellence.
Identification of hub genes in heart failure by integrated bioinformatics analysis and machine learning
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Objective To screen feature genes of heart failure patients through machine learning methods, in order to identify characteristic genes driving heart failure and investigate the progression of heart failure Methods Heart failure patient samples were downloaded from the public database GEO (Gene Expression Omnibus), including the datasets GSE116250, GSE120895, and GSE59867.
Women, Black men less likely to receive lifesaving heart failure treatments: Study
Medical Xpress - Cardiology
JANUARY 4, 2024
Access to potentially lifesaving heart failure treatments has increased in recent years, but women and Black men remain far less likely to receive them, new research suggests.
Experimental study of the bilateral asymmetric single-rivet occluder device for transcatheter patent foramen ovale closure with reserved interatrial septal puncture area
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Purpose To evaluate a noval bilateral asymmetric single-rivet occluder with reserved interatrial septal puncture area for treating patent foramen ovale (PFO). Materials and methods The study established a pig model of patent foramen ovale (PFO) by puncturing the oval fossa and then performing high-pressure balloon dilation. A specially designed bilateral asymmetric occluder for the reserved interatrial septal puncture area was then. used to close the PFO through catheter-based intervention.
Green Space May Reduce the Risk of Childhood Myopia Development
HCPLive
JANUARY 4, 2024
A new cohort study in China reports suggests the structure of green space decreased the relative risk of myopia among school-aged children.
Impact of clinical variables on outcomes in refractory cardiac arrest patients undergoing extracorporeal cardiopulmonary resuscitation
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Background In the past two decades, extracorporeal resuscitation (ECPR) has been increasingly used in the management of refractory cardiac arrest (CA) patients. Decision algorithms have been used to guide the care such patients, but the effectiveness of such decision-making tools is not well described. The aim of this study was to compare the rate of survival with a good neurologic outcome of patients treated with ECPR meeting all criteria of a clinical decision-making tool for the initiation of
Endocrinology Month in Review: December 2023
HCPLive
JANUARY 4, 2024
Our endocrinology month in review spotlights our most popular content from December 2023. Our list of the most popular content from the past month includes the ADA Standards of Care—2024, label updates, a feature from our This Year in Medicine series, and more!
A cross-sectional analysis of zinc and copper levels and their relationship to cardiovascular disease risk markers in Qatar biobank participants
Frontiers in Cardiovascular Medicine
JANUARY 4, 2024
Cardiovascular diseases (CVD) are the leading cause of mortality and morbidity worldwide. Dietary intake, particularly zinc (Zn) and copper (Cu) has been strongly associated with CVD. These trace elements play a crucial role in human enzyme activity, suppressing inflammation, catalyzing lipid metabolism enzymes, reducing oxidative stress, and regulating glucose metabolism.
Here’s Why Cardiologists Recommend GEMMS ONE EHR
GEMMS
JANUARY 4, 2024
Amidst the ongoing transformations in the healthcare landscape, cardiologists are increasingly embracing Electronic Health Record (EHR) software to enhance workflow efficiency and elevate the quality of patient care. As we explore the crucial role of EHR software, we will also unravel the reasons behind the surge in popularity of GEMMS ONE among cardiologists.
Hepatology Month in Review: December 2023
HCPLive
JANUARY 4, 2024
Our December 2023 month in review highlights top news in HCV screening, treatment with DAAs, and MASLD risk factors.
Unveiling a Year of Medical Excellence: Celebrating 2023's Milestones and Beyond
ADN Center of Excellence
JANUARY 4, 2024
As we bid farewell to an extraordinary year, we stand in awe of the incredible journey we've embarked upon in 2023. It's with immense pride and joy that we reflect on the milestones and accomplishments achieved by our collective dedication to advancing medical education and innovation. The canvas of 2023 was painted with vibrant hues of knowledge and expertise, marked by a plethora of events and trainings that illuminated the path toward medical excellence.
Positive Airway Pressure Therapy Increases Leptin Levels for Smokers with OSA
HCPLive
JANUARY 4, 2024
A new study found smoking affects serum leptin levels for patients with obstructive sleep apnea on positive airway pressure therapy. Serum leptin levels increased in 40% of active smokers with obstructive sleep apnea but did not increase in any of the non-smokers.
Pilot Study of Supervised Exercise and Intensive Medical Therapy in Patients with INOCA and Coronary Microvascular Dysfunction
The American Journal of Cardiology
JANUARY 4, 2024
Publication date: Available online 4 January 2024 Source: The American Journal of Cardiology Author(s): Christopher L. Schumann, Zachariah B. Nealy, Roshin C. Mathew, Yang Yang, Pelbreton C. Balfour, Peter W.
Positive Results Seen in Orismilast Treatment of Patients with HS
HCPLive
JANUARY 4, 2024
Twice-daily PDE4-inhibition using 10–40 mg of orismilast showed promise though further studies may be necessary to validate these findings.
Advanced Magnetic Resonance Imaging (MRI) to Define the Microvascular Injury Driven by Neuroinflammation in the Brain of a Mouse Model of Hypertension
Hypertension Journal
JANUARY 4, 2024
Hypertension, Ahead of Print. BACKGROUND:Hypertension is one of the main risk factors for dementia and cognitive impairment.METHODS:We used the model of transverse aortic constriction to induce chronic pressure overload in mice. We characterized brain injury by advanced translational applications of magnetic resonance imaging. In parallel, we analyzed peripheral target organ damage induced by chronic pressure overload by ultrasonography.
Let's personalize your content